Download PDF
CC BY 4.0 · Rev Bras Ginecol Obstet 2023; 45(03): 161-168
DOI: 10.1055/s-0043-1768564
Febrasgo Position Statement

Fertility preservation in gynecologic cancer patients

Number 3 – March 2023
Suzana Arenhart Pessini 
1   Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
,
Jesus Paula Carvalho 
2   Universidade de São Paulo, São Paulo, SP, Brazil
,
Ricardo dos Reis 
3   Hospital de Câncer de Barretos, Barretos, SP, Brazil
,
Agnaldo Lopes da Silva Filho 
4   Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
,
Walquíria Quida Salles Pereira Primo 
5   Universidade de Brasília, Brasília, DF, Brazil
› Author Affiliations
› Further Information
   Permissions and Reprints

Keypoints

  • Fertility preservation in cancer patients is possible through conservative surgery or assisted reproduction techniques.

  • Patients of childbearing age with a diagnosis of malignancy benefit from reproductive counseling.

  • Oncological and reproductive information results in lower rates of regret, even when the patient chooses to abandon conservative treatment.

  • Criteria for indicating conservative treatment in cervical, endometrial and ovarian cancer are presented in this position statement.

  • Conservative treatment modalities in cervical, endometrial and ovarian cancer are discussed together with the respective oncological and reproductive outcomes.

The National Commission Specialized in Gynecology Oncology of the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) endorses this document. The production of content is based on scientific evidence on the proposed theme and the results presented contribute to clinical practice.




Publication History

Article published online:
24 May 2023

© 2023. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Stewart K, Campbell S, Frumovitz M, Ramirez PT, McKenzie LJ. Fertility considerations prior to conservative management of gynecologic cancers. Int J Gynecol Cancer 2021; 31 (03) 339-44
    CrossrefPubMedSearch in Google Scholar
  • 2 Scott AR, Stoltzfus KC, Tchelebi LT, Trifiletti DM, Lehrer EJ, Rao P. et al. Trends in cancer incidence in US adolescents and young adults, 1973-2015. JAMA Network Open 2020; 3 (12) e2027738
    CrossrefPubMedSearch in Google Scholar
  • 3 Patel A, Galaal K, Burnley C, Faulkner K, Martin-Hirsch P, Bland MJ. et al. Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study. Br J Cancer 2012; 106 (11) 1753-9
    CrossrefPubMedSearch in Google Scholar
  • 4 Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet 2021; 155 Suppl 1: 28-44
    CrossrefPubMedSearch in Google Scholar
  • 5 Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo). Preservação da fertilidade em mulheres com câncer ginecológico. São Paulo: Febrasgo; 2021. (Protocolo Febrasgo –Ginecologia; nº 95/Comissão Nacional Especializada em Ginecologia Oncológica).
    PubMed
  • 6 Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C. et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Int J Gynecol Cancer 2018; 28 (04) 641-55
    CrossrefPubMedSearch in Google Scholar
  • 7 Guimarães YM, Godoy LR, Longatto-Filho A, Reis RD. Management of early-stage cervical cancer: a literature review. Cancers (Basel) 2022; 14 (03) 575
    CrossrefPubMedSearch in Google Scholar
  • 8 Salvo G, Ramirez PT, Leitao MM, Cibula D, Wu X, Falconer H. et al. Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study. Am J Obstet Gynecol 2021; 226 (01) 97.e1-16
    CrossrefPubMedSearch in Google Scholar
  • 9 Segarra-Vidal B, Persson J, Falconer H. Radical trachelectomy. Int J Gynecol Cancer 2021; 31 (07) 1068-74
    CrossrefPubMedSearch in Google Scholar
  • 10 Zhang Q, Li W, Kanis MJ, Qi G, Li M, Yang X. et al. Oncological and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis. Oncotarget 2017; 8 (28) 46580-92
    CrossrefPubMedSearch in Google Scholar
  • 11 Schmeler KM, Pareja R, Lopez Blanco A, Fregnani JH, Lopes A, Perrota M. et al. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer 2021; 31 (10) 1317-25
    CrossrefPubMedSearch in Google Scholar
  • 12 Gwacham NI, McKenzie ND, Fitzgerald ER, Ahmad S, Holloway RW. Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives. Gynecol Oncol 2021; 162: 809-15
    CrossrefPubMedSearch in Google Scholar
  • 13 Smith ES, Moon AS, O’Hanlon R, Leitao Jr MM, Sonoda Y, Abu-Rustum NR. et al. Radical trachelectomy for the treatment of early stage cervical cancer: a systematic review. Obstet Gynecol 2020; 136 (03) 533-42
    CrossrefPubMedSearch in Google Scholar
  • 14 Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol 2016; 17 (06) e240-53
    CrossrefPubMedSearch in Google Scholar
  • 15 Shah JS, Jooya ND, Woodard TL, Ramirez PT, Fleming ND, Frumovitz M. Reproductive counseling and pregnancy outcomes after radical trachelectomy for early stage cervical cancer. J Gynecol Oncol 2019; 30 (03) e45
    CrossrefPubMedSearch in Google Scholar
  • 16 Gien LT, Covens A. Fertility-sparing options for early stage cervical cancer. Gynecol Oncol 2010; 117 (02) 350-7
    CrossrefPubMedSearch in Google Scholar
  • 17 Speiser D, Mangler M, Köhler C, Hasenbein K, Hertel H, Chiantera V. et al. Fertility outcome after radical vaginal trachelectomy: a prospective study of 212 patients. Int J Gynecol Cancer 2011; 21 (09) 1635-9
    CrossrefPubMedSearch in Google Scholar
  • 18 Marques RM, Tsunoda AT, Dias RS, Pimenta JM, Linhares JC, Ribeiro R. Robotic uterine transposition for a cervical cancer patient with pelvic micrometastases after conization and pelvic lymphadenectomy. Int J Gynecol Cancer 2020; 30 (06) 898-9
    CrossrefPubMedSearch in Google Scholar
  • 19 International Agency for Research on Cancer. Cancer today [Internet]. 2020 [cited 2022 Feb 7]. Available from: https://gco.iarc.fr/today/home
    PubMed
  • 20 Koskas M, Amant F, Mirza MR, Creutzberg CL. Cancer of the corpus uteri: 2021 update. Int J Gynaecol Obstet 2021; 155 Suppl. 1: 45-60
    CrossrefPubMedSearch in Google Scholar
  • 21 Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S. et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol 2021; 154: 327-53
    CrossrefPubMedSearch in Google Scholar
  • 22 Qin Y, Yu Z, Yang J, Cao D, Yu M, Wang Y. et al. Oral progestin treatment for early-stage endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer 2016; 26 (06) 1081-91
    CrossrefPubMedSearch in Google Scholar
  • 23 Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S. et al. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. Gynecol Oncol 2014; 133 (02) 229-33
    CrossrefPubMedSearch in Google Scholar
  • 24 Kesterson JP. Fertility preservation in patients with endometrial carcinoma [Internet]. 2022 [cited 2022 Jul 22]. Available from: https://www.uptodate.com/contents/fertility-preservation-in-patients-with-endometrial-carcinoma
    PubMedSearch in Google Scholar
  • 25 Lucchini SM, Esteban A, Nigra MA, Palacios AT, Alzate-Granados JP, Borla HF. Updates on conservative management of endometrial cancer in patients younger than 45 years. Gynecol Oncol 2021; 161 (03) 802-9
    CrossrefPubMedSearch in Google Scholar
  • 26 Li J, Zhu Q, Yang B, Ning C, Liu X, Luo X. et al. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients. Eur J Obstet Gynecol Reprod Biol 2018; 222: 151-4
    CrossrefPubMedSearch in Google Scholar
  • 27 Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD. et al. Ovarian conservation and overall survival in young women with early-stage low-grade endometrial cancer. Obstet Gynecol 2016; 128 (04) 761-70
    CrossrefPubMedSearch in Google Scholar
  • 28 Laurelli G, Falcone F, Gallo MA, Scala F, Losito S, Granata V. et al. Long-term oncologic and reproductive outcomes in young women with early endometrial cancer conservatively treated: a prospective study and literature update. Int J Gynecol Cancer 2016; 26 (09) 1650-7
    CrossrefPubMedSearch in Google Scholar
  • 29 Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM. et al. Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device. Obstet Gynecol 2018; 131 (01) 109-16
    CrossrefPubMedSearch in Google Scholar
  • 30 Novikova OV, Nosov VB, Panov VA, Novikova EG, Krasnopolskaya KV, Andeeva YY. et al. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer. Gynecol Oncol 2021; 161 (01) 152-9
    CrossrefPubMedSearch in Google Scholar
  • 31 Herrera Cappelletti E, Humann J, Torrejón R, Gambadauro P. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis. Hum Reprod Update 2022; 28 (02) 282-95
    CrossrefPubMedSearch in Google Scholar
  • 32 Janda M, Robledo KP, Gebski V, Armes JE, Alizart M, Cummings M. et al. Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial. Gynecol Oncol 2021; 161 (01) 143-51
    CrossrefPubMedSearch in Google Scholar
  • 33 Hanatani M, Yoshikawa N, Yoshida K, Tamauchi S, Ikeda Y, Nishino K. et al. Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age. Int J Clin Oncol 2020; 25 (01) 187-94
    CrossrefPubMedSearch in Google Scholar
  • 34 Ratnavelu ND, Brown AP, Mallett S, Scholten RJ, Patel A, Founta C. et al. Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. Cochrane Database Syst Rev. 2016; (03) CD010360
    CrossrefPubMedSearch in Google Scholar
  • 35 Ovarian cancer/Fallopium tube cancer/Primary peritoneal cancer. Clinical Practice Guidelines in Oncology (NCCN guidelines). Version 1.2022 [Internet]. 2022 [cited 2022 Fev 7]. Available from: https://www.nccn.org/guidelines/guidelines-with-evidence-blocks
    PubMed
  • 36 Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynecol Obstet 2021; 155 Suppl 1: 61-85
    CrossrefPubMedSearch in Google Scholar
  • 37 Daraï E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update 2013; 19 (02) 151-66
    CrossrefPubMedSearch in Google Scholar
  • 38 Nitecki R, Clapp MA, Fu S, Lamiman K, Melamed A, Brady P. et al. Outcomes of the first pregnancy after fertility-sparing surgery for early-stage ovarian cancer. Obstet Gynecol 2021; 137 (06) 1109-18
    CrossrefPubMedSearch in Google Scholar
  • 39 European Society of Human Reproduction and Embryology. Female fertility preservation: guideline [Internet]. Strombeek-Bever: ESHRE; 2020 [cited 2022 Fev 7]. Available from: www.eshre.eu/guidelines
    PubMed